BerGenBio announces a change to its Board of Directors

 

Bergen, Norway, 15 December 2018 – BerGenBio ASA (OSE:BGBIO) announces that Dr.
Susan Foden has, for personal reasons, decided to stand down from her position
as a Non-executive Director and will leave the Board of Directors effective from
1 January 2019. 

BerGenBio’s Board Nominations Committee is currently working on recruiting a new
board member and it’s proposals will be made at the Company’s Annual General
Meeting on 13 March 2019. 

Stein Holst Annexstad, Chairman of the Board of Directors, said: “On behalf of
the Board of Directors and the Company, I would like to thank Sue for her
excellent contribution and valued advice over the past 7 years. We wish her well
for the future.” 

-Ends-

Contacts
Richard Godfrey, CEO, BerGenBio ASA
+47 917 86 304

Rune Skeie, CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading